Biofarm (stock symbol BIO), one of the most important drug manufacturers in Romania, reports significant increases in the first half of the year compared to the same period of 2021: turnover increasing by 17% and a net profit of RON 43.6 million, up by 20%. In addition, Biofarm recorded EBITDA...
If you want to read the entire content, you
need a subscription to Nine O'Clock
This content is for subscriber members only. Subscribe now
Only 59 euros / month or 400 euros / year (VAT not included)
Get access to:
120.000 articles in 32 years of Nine O`Clock 600 new articles every month No ads experience on the website Do you already have an subscriber account? Enter in your account here: Login
